The Insider
Biotech Special Event
The Insider: Biotech Special Event session is a great way to access biotech investment insights, market views and favourite stocks from a panel of industry leaders.**
Matt McNamara
Horizon 3 Biotech
Steven Yatomi-Clarke
Prescient Therapeutics
Meet the Fund Manager
Upcoming Session
Meet the Manager
Get access to some of Australia’s leading fund managers who share their 3 favourite stocks, investment approach and insights on the market.
Each session includes:
- 3 favourite stock opportunities
- Market views for the year ahead
- Investment strategy and approaches
This is a live and interactive online session, and participants are encouraged to ask questions. Joining only requires an internet connection. Spots are limited, so secure yours today.
Book into the next session
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.
Past Sessions
Martin Pretty Equitable Investors
Martin Pretty gained vast financial experience as an investment manager at Thorney Investment Group, helping deliver one of the group’s highest annualised three-year returns (18.2% per annum) as at February 2017. He is the director of several ASX-listed companies and as a financial journalist has contributed to the Australian Financial Review and other reputable publications.
Luke Winchester Merewether Capital
Luke Winchester, managing director and CIO at Merewether Capital, started the company with the goal of building a reputation as one of the leading small and microcap managers in the Australian equities market and is one of the largest investors in the Merewether Capital Inception Fund.
Harley Grosser Capital H Management
Harley Grosser, founder and managing director, founded Capital H Management in 2014 having previously worked for Pie Funds and Bligh Capital. He has been investing in ASX-listed small caps for 12 years and is also the managing director of Australian Rural Capital and non-executive director of Motio.